H pylori Infection

Latest Articles

Resistant Strains of H pylori Across Europe Associated With Historical Antibiotic Use

By

Jessica Nye, PhD

Investigators assessed the link between antibiotic consumption and resistance and H pylori infections in European countries.

Vonoprazan-Based Triple Therapy: Most Effective Worldwide for H pylori

By

Virginia A. Schad, PharmD, RPh

Researchers performed a network meta-analysis to compare the effectiveness of first-line regimens vs standard triple therapy in the treatment of H pylori infection.

HDDT vs BQT for H pylori Eradication

By

Vincent Soreca

Researchers compared the efficacy, adverse events, and compliance of HDDT vs BQT as first-line or rescue regimens and investigated factors contributing to H pylori eradication.

H pylori Eradiation Failure More Frequent Among Patients With HIV Coinfections

By

Jessica Nye, PhD

Researchers aimed to evaluate outcomes of H pylori treatment and identify any risk factors for failure in patients with HIV.

Study Shows Vonoprazan-Based Regimens Noninferior to PPI-Based Triple Therapy

By

Diana Ernst, RPh

Vonoprazan is an oral small molecule potassium-competitive acid blocker.

Abdominal Pain, Diarrhea in COVID-19 Linked to H pylori Infection

By

Rita Aghjayan

Researchers investigated the effects of H pylori on the clinical presentation and disease course of COVID-19 infections.

Trends and Predictions in GC Incident Rates from a Global Perspective

By

Vincent Soreca

Investigators sought to explore the past temporal trends (1988-2012) in gastric cancer incidence rates in 43 countries and to predict future trends (2012-2030).

EndoFaster® Device May Be Effective for Real-Time H pylori Detection

By

Colby Stong

Investigators tested the accuracy of the EndoFaster® device in performing gastric juice analysis, with the goal of reducing the need for gastric biopsies in the detection of H pylori.

H pylori Eradication Rates Higher After 10-Day BQT Than 7-Day STT

By

Jessica Nye, PhD

Researchers compared the efficacy of 10-Day Bismuth Quadruple Therapy vs 7-day Clarithromycin Triple Therapy.

H pylori Infection and Early GC

By

Virginia A. Schad, PharmD, RPh

Researchers assessed the correlation between Helicobacter pylori infection and biological characteristics of early gastric cancer.

Effects of H pylori Antibody Type on Serum Gastric Function

By

Vincent Soreca

Researchers assessed the effects of different H pylori infections on distribution of histopathological characteristics and items of serum gastric function.

H pylori Infection and CKD

By

Emily Pond

Investigators evaluated the relationship among Helicobacter pylori infection, atrophic gastritis, and chronic kidney disease.

Factors Contributing to Eradication of H pylori With Vonoprazan, Amoxicillin

By

Vincent Soreca

A team of investigators conducted a multicenter, randomized, controlled trial to identify factors related to the eradication of H pylori with dual vonoprazan and amoxicillin as first-line therapy.

BMI Linked to Vonoprazan Effectiveness as Second-Line Helicobacter pylori Treatment

By

Colby Stong

A team of investigators sought to determine factors that affect the success of second-line therapy using vonoprazan, a gastric acid secretion inhibitor that improves the success rate of Helicobacter pylori eradication.

Refractory Helicobacter pylori Infection: An AGA Clinical Practice Update

By

Colby Stong

The American Gastroenterological Association issued a clinical practice update to provide clinicians with practical advice on how to manage patients for whom initial treatment for H pylori infection was unsuccessful.

Reflux Esophagitis Following Eradication of Helicobacter pylori-Positive Ulcer Disease

By

Vincent Soreca

Investigators performed a cross-sectional study to assess reflux esophagitis in patients having undergone successful eradication of Helicobacter pylori infection.

Are Routine Exams for Helicobacter pylori in Peptic Duodenitis Necessary?

By

Colby Stong

Study finds that only 2% of duodenal biopsies demonstrated H pylori; therefore, routine examination of chronic peptic duodenitis may be unnecessary.

Triple Therapy for Helicobacter pylori Eradication Safe for Adolescents

By

Jessica Nye, PhD

A team of investigators conducted a prospective, multicenter study to assess the safety of H pylori eradication therapy in adolescent students.

Helicobacter pylori Eradication Associated With Reduced Risk of Dyslipidemia

By

Vincent Soreca

A team of investigators conducted a large retrospective, cohort study to assess whether a longitudinal link exists between H pylori infection and the risk of developing dyslipidemia.

AI Tool Shows Promise for Predicting Gastric Cancer Risk After Helicobacter Pylori Eradication

By

Vincent Soreca

A team of investigators explored the ability of different machine learning models to predict the risk of gastric cancer development in patients who had undergone eradication of Helicobacter pylori infection.